ITPKB and lymphoma: We therefore hypothesized that this intronic deletion would lead to aberrant splicing, resulting in a truncated/decayed ITPKB gene product with loss of function/expression, leading to promotion of the growth and proliferation of lymphoma cells in the affected patient.